Speaker(s):
Hannah Spence PharmD, PGY1 resident, Geisinger - has nothing to disclose.
Moderator(s):
Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Identify risk factors and clinical presentation of myocardial infarction.
Summarize appropriate guideline directed treatment strategies.
Critically analyze recent literature on anticoagulants in post-MI care.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 0.50 AAPA Category I CME
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation Credit

Facebook
X
LinkedIn
Forward